Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
PMID: 25249298, PMCID: PMC4323804, DOI: 10.1161/jaha.114.001197
Special considerations for different populations Treatment duration considerations shift based on age, sex, and underlying health conditions
(0) (0) Sorry, no reviews match your current selections Related products Rated 4.60 out of 5From 6.95Add to basket This product has multiple variants
Yeo and colleagues explained that with rising obesity in the U.S., the increasing prevalence of GLP-1 receptor agonists prescribed for obesity may contribute to drug shortages. Further, drug shortages may exacerbate the existing nationwide racial and ethnic disparities in GLP-1 receptor agonist prescriptions, they wrote, adding that the results suggest a call for strategies to address the growing demand and ensure equitable access to the drugs.
Due to the nature of research chemicals, products cannot be returned once shipped
